Prevalence of Genotypic Resistance to Antiretroviral Drugs in Treatment-Naive Youths Infected with Diverse HIV Type 1 Subtypes and Recombinant Forms in Dar es Salaam, Tanzania
- 1 April 2011
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 27 (4), 377-382
- https://doi.org/10.1089/aid.2010.0113
Abstract
As human immunodeficiency virus (HIV) diversity may have an impact on both vaccine efficacy and drug resistance, it is important to have knowledge of circulating genetic variants. With widespread use of antiretroviral (ARV) drugs in Africa, one of the major potential challenges is the risk of emergence of ARV drug-resistant HIV strains. This study aimed to determine the circulating HIV subtypes and recombinant forms, as well as the prevalence of ARV drug resistance mutations, among 75 treatment-naive HIV-infected youths in Dar es Salaam, Tanzania. Gag (n = 48), partial pol (n = 44), and partial env (n = 35) sequencing was performed; all three regions were sequenced in 26 samples. Evidence of infection with recombinant viruses was found in 12 (46%) participants; AC recombinants were the most commonly detected and they were identified in six (23%) participants. Of individuals infected with nonrecombinant strains, subtype A was most commonly detected in seven (27%) participants, followed by subtype C detected in six (23%) participants and subtype D detected in one (4%) participant. Among the pol sequences from 44 individuals, three (7%) had resistance to nucleoside reverse transcriptase (RT) inhibitors and four (9%) had nonnucleoside RT inhibitor resistance mutations. Of these, three (7%) individuals were infected with viruses with cross-resistance mutations to both classes of RT inhibitors. These resistant mutations were all associated with drugs currently used in first-line therapy and in the prevention of vertical transmission. This high prevalence of resistance mutations is of considerable concern in apparently drug-naive populations as it may result in treatment failure and the spread of ARV-resistant strains.Keywords
This publication has 13 references indexed in Scilit:
- Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, TanzaniaAIDS Research and Therapy, 2008
- MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0Molecular Biology and Evolution, 2007
- HIV Type 1 Subtype CgagandnefDiversity in Southern AfricaAIDS Research and Human Retroviruses, 2007
- Prevalence of HIV Infection Among Young Adults in the United States: Results From the Add Health StudyAmerican Journal of Public Health, 2006
- Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, BrazilAnais da Academia Brasileira de Ciências, 2004
- HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest TanzaniaAIDS Research and Human Retroviruses, 2004
- HIV Type 1 Subtypes among Bar and Hotel Workers in Moshi, TanzaniaAIDS Research and Human Retroviruses, 2003
- Evaluating Clinical Isolates for Their Phenotypic and Genotypic Resistance Against Anti-HIV DrugsMethods in molecular medicine, 1999
- Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay.Genome Research, 1995
- Estimating effective population size from samples of sequences: a bootstrap Monte Carlo integration methodGenetics Research, 1992